Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: Cooperative interactions in vivo

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 353-363

  Lahoz, Enrique Gómez ^a,e   Liegeois, Nanette J ^a   Zhang, Pumin ^c   Engelman, Jeffrey A ^a   Horner, James ^a   Silverman, Adam ^a   Burde, Ronald ^a   Roussel, Martine F ^b   Sherr, Charles J ^b   Elledge, Stephen J ^c   DePinho, Ronald A ^a,d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN E;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

EID: 0032913472     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.1.353     Document Type: Article

References (62)

1. Ahuja, H. S., Y. Zhu, and Z. Zakeri. 1997. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death. Dev. Genet. 21:258-267.
2. Alevizopoulos, K., J. Vlach, S. Hennecke, and B. Amati. 1997. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16:5322-5333.
3. Assoian, R. K. 1997. Control of the G1 phase cyclin-dependent kinases by mitogenic growth factors and the extracellular matrix. Cytokine Growth Factor Rev. 8:165-170.
4. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
5. Bodrug, S. E., B. J. Warner, M. L. Bath, G. J. Lindeman, A. W. Harris, and J. M. Adams. 1994. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 13:2124-2130.
6. Bortner, D. M., and M. P. Rosenberg. 1997. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell. Biol. 17:453-459.
7. Bresnahan, W. A., I. Boldogh, T. Ma, T. Albrecht, and E. A. Thompson. 1996. Cyclin E/dk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Cell Growth Differ. 7:1283-1290.
8. Broekhuyse, R. M., E. D. Kuhlmann, and A. L. Stols. 1976 Lens membranes. II. Isolation and characterization of the main intrinsic polypeptide (MIP) of bovine lens fiber membranes. Exp. Eye Res. 23:365-371.
9. Chepelinsky, A. B., C. R. King, P. S. Zelenka, and J. Piatigorsky. 1985. Lens-specific expression of the chloramphenicol acetyltransferase gene promoted by 5′ flanking sequences of the murine alpha A-crystallin gene in explanted chicken lens epithelia. Proc. Natl. Acad. Sci. USA 82:2334-2338.
10. Connell-Crowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/CDK4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287-301.
11. Duronio, R. J., and P. H. O'Farrell. 1995. Developmental control of the G1 to S transition in Drosophila: cyclin E is a limiting downstream target of E2F. Genes Dev. 9:1456-1468.
12. Duronio, R. J., A. Brook, N. Dyson, and P. H. O'Farrell. 1996 E2F-induced S phase requires cyclin E. Genes Dev. 10:2513-2525.
13. Elledge, S. J., and J. W. Harper. 1994. CDK inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6:847-852.
14. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
15. Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:2364-2372.
16. Finley, R. L., Jr., B. J. Thomas, S. L. Zipursky, and R. Brent. 1996. Isolation of Drosophila cyclin D, a protein expressed in the morphogenetic furrow before entry into S phase. Proc. Natl. Acad. Sci USA 93:3011-3015.
17. Fromm, L., and P. A. Overbeek. 1996. Regulation of cyclin and cyclin-dependent kinase gene expression during lens differentiation requires the retinoblastoma protein. Oncogene 12:69-75.
18. Furuya, Y., S. Ohta, K. Yasuda, and H. Ito. 1997. Enhanced expression of cyclin-dependent kinase apoinhibitor in apoptosis of androgen-independent prostatic cancer cell line induced by calcium ionophore. Anticancer Res. 17:2391-2394.
19. Gao, C. Y., Z. Zakeri, Y. Zhu, H. He, and P. S. Zelenka. 1997. Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens. Dev. Genet. 20:267-275.
20. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol 119:493-501.
21. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
22. INK4B/MTS2-related CDK6 inhibitor correlates with wild-type pRb function. Genes Dev. 8:2939-2952.
23. Hatakeyama, M., J. A. Brill, G. R. Fink, and R. A. Weinberg. 1994. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 8:1759-1771.
24. Kato, J., and C. J. Sherr. 1993. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA 90:11513-11517.
25. Kip1) of cyclin-dependent kinase-4 activation. Cell 79:487-496.
26. Koh, J., G. H. Enders, B. D. Dynlacht, and E. Harlow. 1995. Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506-510.
27. Lovec, H., A. Grzeschiczek, M. B. Kowalski, and T. Moroy. 1994. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 13:3487-3495.
28. Lukas, J., M. Pagano, Z. Staskova, G. Draetta, and J. Bartek. 1994. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707-718.
29. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
30. Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1479-1492.
31. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
32. McAvoy, J. W. 1980. Beta- and gamma-crystallin synthesis in rat lens epithelium explanted with neural retina. Differentiation 17:85-91.
33. ink4a requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289-6293.
34. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
35. Miller, M. W., and R. S. Mowakowski. 1988. Use of bromodeoxyuridine immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system. Brain Res. 457:44-52.
36. Morgenbesser, S. D., B. O. Williams, T. Jacks, and R. A. DePinho. 1994 p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-74.
37. Morgenbesser, S. D., N. Schreiber-Agus, M. Bidder, K. A. Mahon, P. A. Overbeek, J. Horner, and R. A. DePinho. 1995. Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J. 14:743-756.
38. Murata, V., T. Kudoh, H. Sugiyama, K. Toyoshima, and T. Akiyama. 1997. The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett. 409:41-45.
39. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
40. Ohtsubo, M., and J. M. Roberts. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912.
41. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
42. Overbeek, P. A., A. B. Chepelinsky, J. S. Khillan, J. Piatigorsky, and H. Westphal. 1985. Lens-specific expression and developmental regulation of the bacterial chloramphenicol acetyltransferase gene driven by the murine alpha A-crystallin promoter in transgenic mice. Proc. Natl. Acad. Sci. USA 82:7815-7819.
43. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romano, G. DalSal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
44. Park, D. S., B. Levine, G. Ferrari, and L. A. Greene. 1997. Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J. Neurosci. 17: 8975-8983.
45. Piatigorsky, J. 1981. Lens differentiation in vertebrates. A review of cellular and molecular features. Differentiation 19:134-153.
46. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
47. Rao, S. S., and D. S. Kohtz. 1995. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J. Biol. Chem. 270:4093-4100.
48. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
49. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
50. Robles, A. I., F. Larcher, K. B. Whalin, R. Murillas, E. Richie, I. B. Gimenez-Conti, J. L. Jorcano, and C. J. Conti. 1996. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc. Natl. Acad. Sci. USA 93:7634-7638.
51. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
52. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
53. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
54. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
55. Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630.
56. Sicinski, P., J. L. Donaher, Y. Geng, S. B. Parker, H. Gardner, M. Y. Park, R. L. Robker, J. S. Richards, L. K. McGinnis, J. D. Biggers, J. J. Eppig, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1996. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474.
57. Takemoto, L., J. Kuck, and K. Kuck. 1988. Changes in the major intrinsic polypeptide (MIP26K) during opacification of the Emory mouse lens. Exp. Eye Res. 47:329-336.
58. Terui, Y., Y. Furukawa, J. Kikuchi, and M. Saito. 1995. Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest. J. Cell. Physiol. 164:74-84.
59. Vallance, S. J., H. M. Lee, M. F. Roussel, S. A. Shurtleff, J. Kato, D. K. Strom, and C. J. Sherr. 1994. Monoclonal antibodies to mammalian D-type G1 cyclins. Hybridoma 13:37-44.
60. Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 369:669-671.
61. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
62. KIP2 indicates a role in Beckwith-Wiedemenn syndrome. Nature 387:151-158.